相似文献/References:
[1]周引德,傅鸿鹏.基层医疗机构药品配备使用情况分析[J].卫生经济研究,2016,(05):38.
[2]赵 静.药品价格改革问题研究[J].卫生经济研究,2016,(07):51.
[3]黄泽华,潘 越,钭江苑,等.药物经济学在医保决策中的应用[J].卫生经济研究,2017,(03):37.
[4]胡善联.药品购销“两票制”政策的理论和实践[J].卫生经济研究,2017,(04):8.
[5]乔家骏,曾旖旎,傅鸿鹏.“两票制”对药企经济运行及药品价格的影响[J].卫生经济研究,2018,(10):61.
QIAO Jia-jun,ZENG Yi-ni,FU Hong-peng.The Influence of “Two-vote System” on the Economic Operation of Pharmaceutical Companies and Drug Prices[J].Journal Press of Health Economics Research,2018,(07):61.
[6]吴 天.药品集中采购价格与药品费用控制研究[J].卫生经济研究,2018,(12):32.
WU Tian.Research on Centralized Purchasing Price and Drug Cost Control of Medicines[J].Journal Press of Health Economics Research,2018,(07):32.
[7]殷 婷,汤少梁.基于消费者剩余理论的患者药品福利研究[J].卫生经济研究,2019,(02):13.
YIN Ting,TANG Shao-liang.Research on Patient Drug Welfare Based on Consumer Surplus Theory[J].Journal Press of Health Economics Research,2019,(07):13.
[8]潘 静,王艳翚.区域差异化背景下我国23个省市药价水平比较分析[J].卫生经济研究,2019,(02):49.
PAN Jing,WANG Yan-hui.Comparative Analysis of Drug Price Levels in 23 Provinces and Cities in China under the Background of Regional Differentiation[J].Journal Press of Health Economics Research,2019,(07):49.
[9]舒 茜,姚峥嵘,王艳翚,等.药品带量采购政策的利益相关者分析[J].卫生经济研究,2019,(08):8.
SHU Qian,YAO Zheng-rong,WANG Yan-hui,et al.Stakeholder Analysis of Drug Consumption Policy[J].Journal Press of Health Economics Research,2019,(07):8.
[10]黎东生,白雪珊.带量采购降低药品价格的一般机理及“4+7招采模式”分析[J].卫生经济研究,2019,(08):10.
LI Dong-sheng,BAI Xue-shan.The General Mechanism of Reducing the Price of Medicines by Quantity Purchase and the Analysis of “4+7 Recruitment Mode”[J].Journal Press of Health Economics Research,2019,(07):10.